Literature DB >> 2933497

Obesity, acanthosis nigricans, insulin resistance, and hyperandrogenemia: pediatric perspective and natural history.

G E Richards, A Cavallo, W J Meyer, M J Prince, E J Peters, C A Stuart, E R Smith.   

Abstract

We studied the syndrome of acanthosis nigricans, obesity, insulin resistance, and hyperandrogenemia in 22 patients. Although isolated case reports in adolescents have appeared, this syndrome has not received full recognition as a pediatric entity. Our patients (17 girls, five boys) had a mean weight 5.7 SD above the mean for age, although mean height was only 0.5 SD above the mean for age. All patients had acanthosis nigricans. Their insulin resistance was significantly greater than that in a control group with comparable obesity. Fasting insulin concentration was 5.25 microU/ml in lean controls, 19.6 microU/ml in obese controls, and 49.8 microU/ml in study patients (P less than 0.002). Mean glucose disappearance rate during an insulin tolerance test was 6.7%/min in lean controls, 5.19%/min in obese controls, and 2.35%/min in study patients (P less than 0.02). After menarche, mean plasma testosterone concentration was 106 ng/dl, compared with less than 50 ng/dl in all lean and obese control patients. Data derived from our series of patients lead us to conclude that (1) this is a genetic syndrome, although the exact mode of inheritance is unclear; (2) the natural history of the syndrome invariably begins with the onset of obesity, followed by acanthosis nigricans that worsens with progressive weight gain; (3) acanthosis nigricans is thus a marker for hyperinsulinemia, which occurs before hyperandrogenemia; (4) hyperandrogenemia occurs only after menarche. Identification of this syndrome should permit monitoring for the development of hyperandrogenemia during puberty and determination of other affected family members.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2933497     DOI: 10.1016/s0022-3476(85)80182-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  Endothelial dysfunction in obese non-hypertensive children without evidence of sleep disordered breathing.

Authors:  Rakesh Bhattacharjee; Wadha H Alotaibi; Leila Kheirandish-Gozal; Oscar Sans Capdevila; David Gozal
Journal:  BMC Pediatr       Date:  2010-02-15       Impact factor: 2.125

Review 2.  How possible is the prevention of polycystic ovary syndrome development in adolescent patients with early onset of hyperandrogenism.

Authors:  D Apter
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

3.  Energy expenditure of the physical activity across the curriculum intervention.

Authors:  Jeffery J Honas; Richard A Washburn; Bryan K Smith; Jerry L Greene; Joseph E Donnelly
Journal:  Med Sci Sports Exerc       Date:  2008-08       Impact factor: 5.411

4.  State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).

Authors:  David H Geller; Danièle Pacaud; Catherine M Gordon; Madhusmita Misra
Journal:  Int J Pediatr Endocrinol       Date:  2011-08-26

5.  Social anxiety, depression and self-esteem in obese adolescent girls with acanthosis nigricans.

Authors:  Özgür Pirgon; Gonca Sandal; Cem Gökçen; Hüseyin Bilgin; Bumin Dündar
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.